أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _____      ______   _    _      ___    __    __  
|  __ \\   /_   _// | |  | ||   / _ \\  \ \\ / // 
| |  \ ||   -| ||-  | |/\| ||  / //\ \\  \ \/ //  
| |__/ ||   _| ||_  |  /\  || |  ___  ||  \  //   
|_____//   /_____// |_// \_|| |_||  |_||   \//    
 -----`    `-----`  `-`   `-` `-`   `-`     `